JAG1 and head and neck squamous cell carcinoma: Our findings contributed to clarify the regulatory mechanisms of the AGs related to the TIME and implied that these AGs might be functional prognostic biomarkers for predicting clinical outcomes of HNSCC patients and provide new targets for improving the immunotherapy response.